News
Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando
- Category: News
- Created on 16 May 2013
Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up data of the SRS™ pivotal study at the Digestive Disease Week in Orlando on May 18-21st 2013.
Successful five-year follow-up data from SRS™ pilot study
- Category: News
- Created on 05 May 2013
Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The pilot study had been conducted at the Deenanath Mangeshkar Hospital and Research Center in Pune, India in 2007. These are the first multi-year clinical follow-up results to be reported with respect to the SRS™.
Medigus Signed a Distribution Agreement in China
- Category: News
- Created on 12 March 2013
Local distributor to purchase SRS™II systems for a minimum of $3.85 million.
Medigus completed $8M private placement by OrbiMed
- Category: News
- Created on 04 March 2013
Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed Israel, was appointed chairman of the board of directors of Medigus.
Columbia Medical Center Offers SRS Procedures
- Category: News
- Created on 13 February 2013
Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.
Medigus announces an exclusive distribution agreement for the SRS™II in Turkey
- Category: News
- Created on 16 January 2013
Medigus (TASE:MDGS) announces an exclusive distribution agreement for the SRS™II in Turkey.
Medigus announces $8M private placement by OrbiMed
- Category: News
- Created on 07 January 2013
Medigus (TASE:MDGS) announces a private placement by OrbiMed Israel Partners LP in the amount of $8 million.
SRS Listed First in the Innovation Section of The Best Of Medgadget 2012
- Category: News
- Created on 31 December 2012
Medigus (TASE:MDGS) announces that the SRS was listed first in the Innovation section of The Best Of Medgadget 2012.
BLOOMBERG: (BFW) Israel’s Medigus Seeks to Move HQ to U.S., Mulls Share Sale: CEO
- Category: News
- Created on 15 November 2012
By Leon Lazaroff
Nov. 15 (Bloomberg) -- CEO Elazar Sonnenschein spoke in interview at Bloomberg offices in New York.
Medigus announces an exclusive distribution agreement for the SRS™II in Italy
- Category: News
- Created on 06 November 2012
Medigus Ltd (TASE: MDGS) reported today that it had signed an agreement for the distribution of SRS™II devices in Italy. The distributor will distribute the SRS™II in Italy on an exclusive basis during an initial twelve-month term.
Three German medical centers submit NUB applications for increased reimbursement for SRS procedures.
- Category: News
- Created on 06 November 2012
Medigus Ltd (TASE: MDGS) announced today that NUB (Neue Untersuchungs und Behandlungsmethoden) applications were submitted by three medical centers in Germany, for increasing the reimbursement amount which the centers will be eligible to receive for procedures using the Medigus SRS™II endoscopic system for the treatment of GERD.
Medigus announces an exclusive distribution agreement for the SRS™II System in the Sri Lankan market
- Category: News
- Created on 15 October 2012
Medigus Ltd (TASE: MDGS) reported today that it had signed an agreement for the distribution of SRS™II devices in Sri Lanka, with a company which is, to Medigus' best knowledge, an importer and distributor of advanced medical equipment in Sri Lanka.
